EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
2.7.1.113 | 2-fluoro-9-beta-D-arabinofuranosyladenine | - |
Homo sapiens | |
2.7.1.113 | 9-beta-D-arabinofuranosylguanine | - |
Homo sapiens | |
2.7.1.113 | cladribine | - |
Homo sapiens | |
2.7.1.113 | clofarabine | - |
Homo sapiens | |
2.7.1.113 | cytarabine | - |
Homo sapiens | |
2.7.1.113 | gemcitabine | - |
Homo sapiens |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.7.1.113 | Homo sapiens | - |
- |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
2.7.1.113 | CEM cell | - |
Homo sapiens | - |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
2.7.1.113 | DGK | - |
Homo sapiens |
EC Number | General Information | Comment | Organism |
---|---|---|---|
2.7.1.113 | malfunction | dGK depletion in cells results in lower sensitivity to 2-fluoro-9-beta-D-arabinofuranosyladenine, gemcitabine, clofarabine, and 9-beta-D-arabinofuranosylguanine, but slightly higher sensitivity to cladribine and cytarabine | Homo sapiens |